Advertisment
|
|
|
news roundup
The team will meet clients’ expected increased needs for the number of personalized medicines that will require genomic information.
Participation in the high volume of studies for the Catalyst program is by invitation only, with an initial focus on oncology and vaccine sites in the U.S. and Asia-Pacific.
FDA intends to expand the use of Sentinel by leveraging its data for additional research, public health and quality improvement activities.
A summary of the latest new positions, business recognition and milestones in the clinical trials world since last month.
|
|
|
Subscribe
|
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
Advertisment
|
|
|
Mobile Health
Gather is an integrated technology system that can be accessed through any internet-connected device and uses a module-based product suite.
New approaches include using Big Data to identify and understand patient populations, and using new technologies and social media to reach, attract, and keep patients.
Actigraphs were the first wearables used in sleep studies to monitor patients over 10 years so.
|
|
|
Articles
This peer review article discusses ways to prevent patient centricity from becoming a fad through scientific measurement of its ultimate impact.
|
|
Blog Posts
After growing DrugDev TrialNetworks, the new module brings DrugDev databases together for a more efficient site activation process.
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
